ACSL4 and lung cancer: The CPT1A/c-Myc signaling axis reduces lipid peroxide generation in lung cancer cells by suppressing ACSL4 expression and concurrently enhances resistance to ferroptosis through stimulation of the NRF2/GPX4 antioxidant pathway [69].